At the time of initial diagnosis, the patient’s serum tumor marker levels were markedly elevated, with a carcinoembryonic antigen (CEA) of 821 ng/mL and a carbohydrate antigen 19-9 (CA19-9) of 18,573 U/mL. The gene discussed is CEACAM5; the disease is neoplasm.